Ghafouri-Fard Soudeh, Shoorei Hamed, Anamag Farhad Tondro, Taheri Mohammad
Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Front Oncol. 2020 Nov 30;10:608975. doi: 10.3389/fonc.2020.608975. eCollection 2020.
Cell cycle is regulated by a number of proteins namely cyclin-dependent kinases (CDKs) and their associated cyclins which bind with and activate CDKs in a phase specific manner. Additionally, several transcription factors (TFs) such as E2F and p53 and numerous signaling pathways regulate cell cycle progression. Recent studies have accentuated the role of long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) in the regulation of cell cycle. Both lncRNAs and miRNAs interact with TFs participating in the regulation of cell cycle transition. Dysregulation of cell cycle regulatory miRNAs and lncRNAs results in human disorders particularly cancers. Understanding the role of lncRNAs, miRNAs, and TFs in the regulation of cell cycle would pave the way for design of anticancer therapies which intervene with the cell cycle progression. In the current review, we describe the role of lncRNAs and miRNAs in the regulation of cell cycle and their association with human malignancies.
细胞周期受多种蛋白质调控,即细胞周期蛋白依赖性激酶(CDK)及其相关的细胞周期蛋白,它们以阶段特异性方式与CDK结合并激活CDK。此外,几种转录因子(TF)如E2F和p53以及众多信号通路调节细胞周期进程。最近的研究强调了长链非编码RNA(lncRNA)和微小RNA(miRNA)在细胞周期调控中的作用。lncRNA和miRNA都与参与细胞周期转换调控的TF相互作用。细胞周期调控miRNA和lncRNA的失调会导致人类疾病,尤其是癌症。了解lncRNA、miRNA和TF在细胞周期调控中的作用将为设计干预细胞周期进程的抗癌疗法铺平道路。在本综述中,我们描述了lncRNA和miRNA在细胞周期调控中的作用及其与人类恶性肿瘤的关联。